2BBBullish & Bearish
Starling Oncology, Inc. (STLN) trades on NASDAQ. It operates in the Health Care sector, Medical Care Facilities industry. Its current 2BB score is 42 out of 100.
Starling Oncology, Inc.’s current 2BB score is 42 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 62 | High |
| Momentum | 100 | Strongly Improving |
| Financial strength | 35 | Weak |
| Quality | 93 | Very Strong |
| Risk | 61 | High |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-10 | — | -0.0122 | — | $188.00M |
| 2026-11-11 | — | -0.049 | — | $172.43M |
| 2026-08-06 | — | -0.0646 | — | $156.75M |
| 2026-05-07 | -0.02 | -0.0783 | $147.44M | $144.67M |